Evidence is emerging for the regulation of platelet function at sites
of vascular injury or thrombosis by multiple platelet recognition site
s in fibrinogen. This study examined the interaction of platelets with
immobilized fibrinogen degradation products, fragments D and E. A 60
kDa D fragment (D-60) and 30 kDa fragment E supported the adhesion of
activated platelets in a static system, despite the absence of gamma c
hain 400-411 dodecapeptide and RGD sequences. Moreover, platelet adhes
ion to these fragments was incompletely inhibited by EDTA. In the abse
nce of divalent cations, ADP-stimulated platelet adhesion to fragments
D-60 or E constituted 31 +/- 12% and 33 +/- 10% (mean +/- SD, n=23) o
f adhesion to intact fibrinogen in the presence of divalent cations, r
espectively. This EDTA-resistant adhesion was distinctly modulated by
thrombin which preferentially supported platelet adhesion to fragment
E, and chymotrypsin which selectively supported platelet adhesion to f
ragment D-60. Furthermore, two potent inhibitors of fibrinogen binding
, the 10E5 monoclonal antibody directed against the GPIIb-IIa complex
and the RGDF peptide, inhibited EDTA-resistant platelet adhesion to fr
agment D-60 but not to fragment E. These data suggest the presence of
novel, non-RGD, non-dodecapeptide containing platelet recognition sequ
ences in both fibrinogen D and E domains which support divalent cation
dependent and independent platelet adhesion via potentially unique bi
nding mechanisms.